Application 125019
- Type
- BLA
- Sponsor
- SPECTRUM PHARMS
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125019 | Zevalin | ibritumomab tiuxetan | 351(a) | Rx | 2026-09-01 |
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ZEVALIN | IBRITUMOMAB TIUXETAN | INJECTABLE; INJECTION | 3.2MG/2ML | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Zevalin | IBRITUMOMAB TIUXETAN | Acrotech Biopharma Inc | 25d367dc-da65-44c9-a844-1bf15339c285 | 2023-04-25 | Boxed warning, Warnings, Adverse reactions | BLA125019 72893-007 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
Documents#
| Document | Submission type | Date |
|---|---|---|
| 56843 | SUPPL | 2018-12-20 |
| 56714 | SUPPL | 2018-12-12 |
| 39784 | SUPPL | 2013-09-09 |
| 39783 | SUPPL | 2013-09-09 |
| 31769 | SUPPL | 2013-09-05 |
| 9541 | SUPPL | 2013-09-05 |
| 31768 | SUPPL | 2011-12-02 |
| 18733 | SUPPL | 2011-11-30 |
| 39782 | SUPPL | 2009-09-18 |
| 9540 | SUPPL | 2009-09-10 |
| 9539 | SUPPL | 2008-03-28 |
| 18732 | SUPPL | 2008-03-27 |
| 39781 | SUPPL | 2007-11-13 |
| 31767 | SUPPL | 2007-11-08 |
| 22770 | ORIG | 2005-12-08 |
| 39780 | SUPPL | 2005-09-15 |
| 31766 | SUPPL | 2005-09-15 |
| 39779 | SUPPL | 2005-08-08 |
| 31765 | SUPPL | 2005-08-08 |
| 39778 | SUPPL | 2005-01-26 |
| 39777 | SUPPL | 2005-01-26 |
| 31764 | SUPPL | 2005-01-26 |
| 9538 | SUPPL | 2005-01-26 |
| 31763 | ORIG | 2004-03-30 |
| 18731 | ORIG | 2004-03-30 |